Gelteq Limited - Ordinary Shares
Gelteq Limited - Ordinary Shares
Share · AU0000218109 · GELS (XNAS)
Overview
No Price
29.01.2026 00:24
Current Prices from Gelteq Limited - Ordinary Shares
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
GELS
USD
29.01.2026 00:24
1,00 USD
-0,04 USD
-3,40 %
Company Profile for Gelteq Limited - Ordinary Shares Share
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.
AI Analysis of Gelteq Limited - Ordinary Shares
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of Gelteq Limited - Ordinary Shares
No AI threads available for this company yet.

Company Data

Name Gelteq Limited - Ordinary Shares
Company Gelteq Limited Ordinary Shares
Symbol GELS
Website https://www.gelteq.com
Primary Exchange XNAS NASDAQ
ISIN AU0000218109
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Nathan Jacob Givoni
Country Australia
Currency USD
Employees 0,0 T
Address 641 Glen Huntly Road, 3162 Caulfield
IPO Date 2024-10-29

Ticker Symbols

Name Symbol
NASDAQ GELS
More Shares
Investors who hold Gelteq Limited - Ordinary Shares also have the following shares in their portfolio:
IPATHA SERIES B BLOOMBERG ALUMINUM SUBINDEX TOTAL RETURN ETN
IPATHA SERIES B BLOOMBERG ALUMINUM SUBINDEX TOTAL RETURN ETN ETF
MODEND (CHN) 20/UND.
MODEND (CHN) 20/UND. Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026